Diagnamed Holdings Corp.
DMED
CNSX
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 453.50K | 64.00K | 56.90K | 96.70K | 57.30K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 471.60K | 133.70K | 72.10K | 84.90K | 114.20K |
Operating Income | -471.60K | -133.70K | -72.10K | -84.90K | -114.20K |
Income Before Tax | -410.90K | -165.10K | -95.70K | -142.00K | -161.20K |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -410.90K | -165.10K | -95.70K | -142.00K | -161.20K |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -410.90K | -165.10K | -95.70K | -142.00K | -161.20K |
EBIT | -471.60K | -133.70K | -72.10K | -84.90K | -114.20K |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Basic Shares Outstanding | 99.32M | 83.12M | 80.76M | 80.05M | 80.05M |
Average Diluted Shares Outstanding | 99.32M | 83.12M | 80.76M | 80.05M | 80.05M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |